Aclarion (ACONW) Competitors $0.06 -0.05 (-44.62%) As of 10/14/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, LFMDP, PIIIW, TALKW, TOIIW, VSEE, NTRA, FMS, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors American Oncology Network Digital Health Acquisition LifeMD P3 Health Partners Talkspace Oncology Institute VSee Health Natera Fresenius Medical Care AG & Co. KGaA Hims & Hers Health American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment. Which has better earnings and valuation, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$62.95KN/AN/AN/AN/A Does the media refer more to AONC or ACONW? In the previous week, American Oncology Network and American Oncology Network both had 1 articles in the media. Aclarion's average media sentiment score of 1.91 beat American Oncology Network's score of 0.08 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment American Oncology Network Neutral Aclarion Very Positive Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A SummaryAmerican Oncology Network and Aclarion tied by winning 1 of the 2 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$355.15M$6.03B$10.50BDividend YieldN/A5.89%5.73%4.80%P/E RatioN/A500.8884.6227.24Price / SalesN/A227.61497.57196.92Price / CashN/A47.1437.5761.53Price / BookN/A5.1012.356.74Net IncomeN/A-$15.55M$3.32B$276.59M7 Day PerformanceN/A-0.53%-1.32%-0.47%1 Month PerformanceN/A3.02%8.15%7.47%1 Year PerformanceN/A14.46%73.83%34.58% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.06-44.6%N/A+71.0%$0.00$62.95K0.007Gap DownHigh Trading VolumeAONCAmerican Oncology NetworkN/A$8.83+3.5%N/A+178.0%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.03+78.8%N/A-83.8%$0.00N/A0.00N/AGap UpLFMDPLifeMDN/A$23.68+0.0%N/A+7.4%$0.00$245.56M0.00230PIIIWP3 Health PartnersN/A$0.01-27.3%N/A-51.0%$0.00$1.46B0.00500TALKWTalkspaceN/A$0.07+27.3%N/A-44.2%$0.00$202.61M0.00500Gap DownHigh Trading VolumeTOIIWOncology InstituteN/A$0.16+14.0%N/A+450.0%$0.00$424.38M0.00660Gap DownHigh Trading VolumeVSEEVSee Health3.5889 of 5 stars$0.70+4.4%$5.00+614.4%-46.8%$0.00$10.42M0.00N/AHigh Trading VolumeNTRANatera2.7137 of 5 stars$173.05+0.6%$192.88+11.5%+31.1%$23.62B$1.70B-90.604,434Analyst ForecastFMSFresenius Medical Care AG & Co. KGaA3.7366 of 5 stars$27.13+0.2%$27.80+2.5%+37.4%$15.89B$19.52B22.231,384Positive NewsGap UpHIMSHims & Hers Health3.3287 of 5 stars$58.13-0.1%$38.92-33.1%+164.1%$13.15B$1.48B72.671,637Analyst ForecastInsider TradeGap Down Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives LFMDP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives VSEE Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
